Three things to know:
1. ViBone was designed by Aziyo Biologics to protect native bone cells and promote bone growth. It features cancellous bone particles as well as demineralized cortical bone fibers and particles.
2. In November, Aziyo Biologics agreed to provide spine device company Surgalign Holdings with ViBone for distribution in the U.S., where the product is now commercially available.
3. Dr. Crowl is chair of the department of orthopedics at Bon Secours St. Francis Medical Center in Midlothian, Va.
More articles on biologics:
Medtronic CEO predicts AI, machine learning as ‘the new frontier for medtech’ — 4 key quotes
40 orthopedic devices receiving FDA clearance in December
Stryker, Smith+Nephew seal 1st acquisitions of 2021: 7 device company notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
